The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The Global Dietary Supplements Market size is expected to reach $245.6 billion by 2023, rising at a market growth of 10% CAGR during the forecast period. Dietary supplements are growing as a vital component within a diet plan of individuals, and these supplements are consumed to provide essential nutritional components, which otherwise would be missing. Growing prevalence of cardiovascular disorders on account of fluctuating diet patterns and inactive lifestyle among the age-group of 30-40 would drive the nutraceuticals market. Awareness about calorie reduction among athletes and gym goers would promote the adoption of supplements within the sports segment.
Based on Product, the Dietary Supplements market segments the market into Tablets & Capsules, Powder, Liquids, Soft Gels, and Others. Based on Ingredients, the market report segments the market into Vitamins & Minerals, Botanicals, Amino Acids, and Enzymes & Others. Based on End User, the Dietary Supplements market segments the market into Adults, Children, Infants & Old Aged, and Pregnant Woman. Based on Regions, the Dietary Supplements market segments the market into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa
The market research report covers the analysis of key stake holders of the Global Dietary Supplements Market. Key companies profiled in the report include Abbott Laboratories, The Carlyle Group, GlaxoSmithKline plc, Alticor (Amway), Glanbia, Plc. (Glanbia Nutritionals), Bayer AG, Archer Daniels Midland Company, E. I. Du Pont De Nemours and Company, Nutraceutics Inc., and Pfizer, Inc.